Metagenomi Inc. MGX) on Tuesday reported a loss of $19.9 million in its second quarter.

In May 2025, the Company reported additional long-term data from its nonhuman primate (“NHP”) study that demonstrated durable and consistent FVIII activity levels through approximately 19 months. Mean ...

Metagenomi (MGX) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.68. This compares to a loss of $0.29 per share a year ago. These figures are ...

Metagenomi, Inc. ( ($MGX) ) has shared an announcement. Metagenomi, Inc. reported its second quarter 2025 financial results and business updates, ...

Venture capital investment in crypto & blockchain startups dropped by 59% in Q2 of 2025, with $1.976B raised across 378 deals ...